162 related articles for article (PubMed ID: 34114677)
1. Successful nutritional control of scratching and clinical signs associated with adverse food reaction: A randomized controlled COSCAD'18 adherent clinical trial in dogs in the United States.
Weemhoff JL; MacLeay JM; Brejda J; Schiefelbein H; Wernimont SM; Gross KL
J Vet Intern Med; 2021 Jul; 35(4):1884-1892. PubMed ID: 34114677
[TBL] [Abstract][Full Text] [Related]
2. Successful nutritional control of scratching and clinical signs associated with adverse food reaction: A randomized controlled COSCAD'18 adherent clinical trial in dogs in the United Kingdom.
Weemhoff JL; MacLeay JM; Brejda J; Schiefelbein H; Wernimont SM; Gross KL
J Vet Intern Med; 2021 Jul; 35(4):1893-1901. PubMed ID: 34114684
[TBL] [Abstract][Full Text] [Related]
3. Letter regarding "Successful nutritional control of scratching and clinical signs associated with adverse food reaction: A randomized controlled COSCAD'18 adherent clinical trial in dogs in the United States" and "Successful nutritional control of scratching and clinical signs associated with adverse food reaction: A randomized controlled COSCAD'18 adherent clinical trial in dogs in the United Kingdom": About misappropriating the COSCAD'18 for an unintended use.
Olivry T; Saridomichelakis M; Santoro D
J Vet Intern Med; 2021 Nov; 35(6):2563-2564. PubMed ID: 34694033
[No Abstract] [Full Text] [Related]
4. Development of a core outcome set for therapeutic clinical trials enrolling dogs with atopic dermatitis (COSCAD'18).
Olivry T; Bensignor E; Favrot C; Griffin CE; Hill PB; Mueller RS; Plant JD; Williams HC;
BMC Vet Res; 2018 Aug; 14(1):238. PubMed ID: 30115047
[TBL] [Abstract][Full Text] [Related]
5. Response to letter regarding "Successful nutritional control of scratching and clinical signs associated with adverse food reaction: A randomized controlled COSCAD'18 adherent clinical trial in the United States" and "Successful nutritional control of scratching and clinical signs associated with adverse food reaction: A randomized controlled COSCAD'18 adherent clinical trial in the United Kingdom".
Weemhoff JL; MacLeay JM; Bredja J; Schiefelbein H; Wernimont SM; Gross KL
J Vet Intern Med; 2021 Nov; 35(6):2565-2566. PubMed ID: 34694024
[No Abstract] [Full Text] [Related]
6. Effect of an insect protein-based diet on clinical signs of dogs with cutaneous adverse food reactions.
Böhm TMSA; Klinger CJ; Gedon N; Udraite L; Hiltenkamp K; Mueller RS
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2018 Oct; 46(5):297-302. PubMed ID: 30541169
[TBL] [Abstract][Full Text] [Related]
7. Non-controlled, open-label clinical trial to assess the effectiveness of a dietetic food on pruritus and dermatologic scoring in atopic dogs.
Witzel-Rollins A; Murphy M; Becvarova I; Werre SR; Cadiergues MC; Meyer H
BMC Vet Res; 2019 Jun; 15(1):220. PubMed ID: 31253166
[TBL] [Abstract][Full Text] [Related]
8. A double blind, randomized, placebo controlled trial of the efficacy, quality of life and safety of food allergen-specific sublingual immunotherapy in client owned dogs with adverse food reactions: a small pilot study.
Maina E; Cox E
Vet Dermatol; 2016 Oct; 27(5):361-e91. PubMed ID: 27426929
[TBL] [Abstract][Full Text] [Related]
9. [Effects of a homeopathic medication on clinical signs of canine atopic dermatitis].
Boehm TMSA; Klinger CJ; Udraite L; Mueller RS
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2020 Aug; 48(4):245-248. PubMed ID: 32823347
[TBL] [Abstract][Full Text] [Related]
10. A randomised, double-blinded comparison between subcutaneous rush and intralympathic allergen immunotherapy induction in atopic dogs.
Mueller RS; Zablotski Y; Baumann K; Boehm T; Kasper B; Klinger C; Monke M; Udraite-Vovk L; Weitzer T; Gedon NKY
Vet Dermatol; 2023 Apr; 34(2):91-98. PubMed ID: 36424528
[TBL] [Abstract][Full Text] [Related]
11. An open-label clinical trial to evaluate the efficacy of an elemental diet for the diagnosis of adverse food reactions in dogs.
Tinsley J; Griffin C; Sheinberg G; Griffin J; Cross E; Gagné J; Romero A
Vet Dermatol; 2024 Feb; 35(1):40-50. PubMed ID: 37621253
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.
Olivry T; Rivierre C; Jackson HA; Murphy KM; Davidson G; Sousa CA
Vet Dermatol; 2002 Apr; 13(2):77-87. PubMed ID: 11972891
[TBL] [Abstract][Full Text] [Related]
13. Use of antipruritic and rehydrating foams on localized lesions of atopic dermatitis in dogs: a small-scale pilot and comparative double-blinded study.
Bensignor EJ; Fabriès LJ
Vet Dermatol; 2018 Oct; 29(5):446-e150. PubMed ID: 30079617
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of the Canine Atopic Dermatitis Lesion Index, a scale for the rapid scoring of lesion severity in canine atopic dermatitis.
Plant JD; Gortel K; Kovalik M; Polissar NL; Neradilek MB
Vet Dermatol; 2012 Dec; 23(6):515-e103. PubMed ID: 23140318
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled clinical trial measuring the effect of a dietetic food on dermatologic scoring and pruritus in dogs with atopic dermatitis.
de Santiago MS; Arribas JLG; Llamas YM; Becvarova I; Meyer H
BMC Vet Res; 2021 Nov; 17(1):354. PubMed ID: 34798876
[TBL] [Abstract][Full Text] [Related]
16. Pilot evaluation of the antipruritic efficacy of a topical transient receptor potential melastatin subfamily 8 (TRPM8) agonist in dogs with atopic dermatitis and pedal pruritus.
Tamamoto-Mochizuki C; Murphy KM; Olivry T
Vet Dermatol; 2018 Feb; 29(1):29-e14. PubMed ID: 28952176
[TBL] [Abstract][Full Text] [Related]
17. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR
Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
[TBL] [Abstract][Full Text] [Related]
18. A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA.
Souza CP; Rosychuk RAW; Contreras ET; Schissler JR; Simpson AC
Vet Dermatol; 2018 Dec; 29(6):489-e164. PubMed ID: 30141223
[TBL] [Abstract][Full Text] [Related]
19. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
Michels GM; Ramsey DS; Walsh KF; Martinon OM; Mahabir SP; Hoevers JD; Walters RR; Dunham SA
Vet Dermatol; 2016 Dec; 27(6):478-e129. PubMed ID: 27647569
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.
Gadeyne C; Little P; King VL; Edwards N; Davis K; Stegemann MR
Vet Dermatol; 2014 Dec; 25(6):512-8, e86. PubMed ID: 25109820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
